Skip to main content
Home

Breadcrumb

  1. Home
  2. Healthcare and Life Science

Healthcare and Life Science

28 March 2023

CodiKoat Appoint Blake Gudgel As CEO

We’re delighted to announce the appointment of Blake Gudgel as our new CEO. Blake joins CodiKoat at a crucial moment in our history. Having spent the last 16 years leading the development and operations efforts in early-stage technology companies in the US & Europe, he will now use ...

11 April 2023

Flusso announces major expansion plan

Flusso has announced a major expansion of its Cambridge-based technical team and offices as it ramps up its new flow and gas sensor R&D activities. The investment is the first phase of an ambitious growth plan by the company’s new owners following its acquisition in August last year...

6 April 2023

Cambridge Science Centre celebrates 10 years of ‘Science WOW’

​​​​​​​For the past ten years, Cambridge Science Centre has inspired over 500,000 children and young people with immersive STEM experiences and mind-blowing events. To kick off the festivities, Cambridge Science Centre (CSC) threw a birthday bash at The Lab cocktail bar, hosted by one o...

6 April 2023

Avacta opens first two US Clinical Investigator sites for AVA6000 Phase 1 clinical study

Memorial Sloan Kettering Cancer Center and Fred Hutch Cancer Center now open for patient enrolment to pre|CISION™ lead programme, AVA6000 ...

7 April 2023

Junior doctors’ strike – advice on emergency care at Addenbrooke’s

Addenbrooke’s Hospital is urging the public to only use A&E for serious emergencies and life-threatening situations during the four day strike by junior doctors (11th – 14th April). ...

5 April 2023

Avacta announces first patient dosed in fifth cohort of AVA6000 Phase Ia Dose Escalation Study

Avacta Group plc, a life sciences company developing innovative, targeted oncology drugs and powerful diagnostics, announces that the first patient has been dosed in the fifth cohort of the first-in-human phase I trial (ALS-6000-101) of AVA6000. This follows the approval of an amended c...

5 April 2023

Pozitive Planet becomes new corporate supporter of Tom’s Trust

Pozitive Planet, a tech driven business with a unique approach to supplying utilities, payments, EV charging, telecoms and carbon offsetting to thousands of UK companies, has become the latest corporate supporter of the children’s brain tumour charity Tom’s Trust. ...

5 April 2023

Arecor appoints Dr. Manjit Rahelu as Chief Business Officer

Manjit is an accomplished strategic deal-maker bringing 25+ years of scientific, commercial and financial experience across major global pharmaceutical and biotechnology companies, specialising in product in and out-licensing, commercial strategy, accelerating growth and M&A ...

6 April 2023

DragonLight launches new Crowdfunder to help finish feature film Six Inches of Soil

Last year we raised enough money to cover the cost of shooting the film. Our small team filmed on the road for 42 days, shot over 120 hours of footage, in nine different English counties. We interviewed over twenty farmers and other experts, attended farming conferences, protests, filme...

4 April 2023

Mosaic Therapeutics closes $28m series A funding and appoints Brian Gladsden as CEO

Company developing targeted oncology therapies spun out of world-leading research at the Wellcome Sanger Institute, in collaboration with the Netherlands Cancer Institute Syncona and Cambridge Innovation Capital invested Former Novartis SVP appointed as CEO to drive growth ambitions...

Pagination

  • First page «
  • Previous page ‹‹
  • …
  • Page 195
  • Page 196
  • Current page 197
  • Page 198
  • Page 199
  • …
  • Next page ››
  • Last page »
Receive our newsletter

Cambridge Network Limited is a company registered in England under company No. 3400152

The Hauser Forum, 3 Charles Babbage Road, Cambridge, CB3 0GT

Email: [email protected], Tel: 01223 746801

© 2026 Cambridge Network. All Rights Reserved.

Website by KISS